We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Thai Ho

Thai H. Ho MD, PhD

Assistant Professor, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona

Dr. Thai Huu Ho is Assistant Professor in the Department of Internal Medicine at the Mayo Clinic in Scottsdale, Arizona, and a practicing genitourinary oncologist at the Mayo Clinic. 

As a physician–scientist, Dr. Ho is involved in translational medicine. He is a member of both the Mayo Clinic Center for Individualized Medicine Epigenomics Group and the Genomic Tumor Board. He has published widely, and his research interests involve mapping epigenomic changes in tumor cells, defining how these changes lead to metastases and how they can be targeted, and identifying tumor signatures that serve as predictors of patient response to targeted drugs. The goal of Dr. Ho's laboratory is to use kidney cancer as a model for identifying vulnerabilities in metastases and extrapolate those findings to other tumors with similar errors. 

Dr. Ho was awarded his MD and PhD (in molecular and cellular biology) by the Medical Scientist Training Program at the Baylor College of Medicine in Houston. He underwent residency training in internal medicine at Washington University/Barnes-Jewish Hospital in St. Louis, and completed his fellowship in medical oncology at the MD Anderson Cancer Center in Houston.